Logo image of COSM

COSMOS HEALTH INC (COSM) Stock Fundamental Analysis

NASDAQ:COSM - Nasdaq - US2214133058 - Common Stock - Currency: USD

0.6165  -0.01 (-1.89%)

After market: 0.615 0 (-0.24%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to COSM. COSM was compared to 108 industry peers in the Health Care Providers & Services industry. Both the profitability and financial health of COSM have multiple concerns. While showing a medium growth rate, COSM is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year COSM has reported negative net income.
COSM had a negative operating cash flow in the past year.
In the past 5 years COSM reported 4 times negative net income.
In the past 5 years COSM always reported negative operating cash flow.
COSM Yearly Net Income VS EBIT VS OCF VS FCFCOSM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -20M -40M -60M

1.2 Ratios

The Return On Assets of COSM (-52.41%) is worse than 87.85% of its industry peers.
The Return On Equity of COSM (-96.67%) is worse than 80.37% of its industry peers.
Industry RankSector Rank
ROA -52.41%
ROE -96.67%
ROIC N/A
ROA(3y)-54.86%
ROA(5y)-35.31%
ROE(3y)-196.24%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
COSM Yearly ROA, ROE, ROICCOSM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500 -500 -1K

1.3 Margins

COSM has a Gross Margin of 8.10%. This is amonst the worse of the industry: COSM underperforms 80.37% of its industry peers.
COSM's Gross Margin has improved in the last couple of years.
COSM does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 8.1%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-17.56%
GM growth 5Y4.63%
COSM Yearly Profit, Operating, Gross MarginsCOSM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -200 -400 -600 -800 -1K

More info and screens

2

2. Health

2.1 Basic Checks

COSM does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, COSM has more shares outstanding
Compared to 5 years ago, COSM has more shares outstanding
Compared to 1 year ago, COSM has a worse debt to assets ratio.
COSM Yearly Shares OutstandingCOSM Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M
COSM Yearly Total Debt VS Total AssetsCOSM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M

2.2 Solvency

Based on the Altman-Z score of -1.93, we must say that COSM is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of COSM (-1.93) is worse than 83.18% of its industry peers.
A Debt/Equity ratio of 0.25 indicates that COSM is not too dependend on debt financing.
COSM has a better Debt to Equity ratio (0.25) than 67.29% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF N/A
Altman-Z -1.93
ROIC/WACCN/A
WACC7.49%
COSM Yearly LT Debt VS Equity VS FCFCOSM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M

2.3 Liquidity

A Current Ratio of 1.44 indicates that COSM should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.44, COSM is in line with its industry, outperforming 47.66% of the companies in the same industry.
COSM has a Quick Ratio of 1.24. This is a normal value and indicates that COSM is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.24, COSM perfoms like the industry average, outperforming 43.93% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.44
Quick Ratio 1.24
COSM Yearly Current Assets VS Current LiabilitesCOSM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M 50M

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 71.84% over the past year.
Looking at the last year, COSM shows a quite strong growth in Revenue. The Revenue has grown by 13.03% in the last year.
The Revenue has been growing slightly by 7.56% on average over the past years.
EPS 1Y (TTM)71.84%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-70.16%
Revenue 1Y (TTM)13.03%
Revenue growth 3Y-1.24%
Revenue growth 5Y7.56%
Sales Q2Q%-3.22%

3.2 Future

Based on estimates for the next years, COSM will show a very strong growth in Earnings Per Share. The EPS will grow by 41.97% on average per year.
COSM is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 15.46% yearly.
EPS Next Y-21.87%
EPS Next 2Y41.97%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year6.66%
Revenue Next 2Y15.46%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
COSM Yearly Revenue VS EstimatesCOSM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
COSM Yearly EPS VS EstimatesCOSM Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -0.2 -0.4 -0.6

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

COSM reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 60.44, the valuation of COSM can be described as expensive.
The rest of the industry has a similar Price/Forward Earnings ratio as COSM.
COSM's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 22.68.
Industry RankSector Rank
PE N/A
Fwd PE 60.44
COSM Price Earnings VS Forward Price EarningsCOSM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
COSM Per share dataCOSM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 -2

4.3 Compensation for Growth

A more expensive valuation may be justified as COSM's earnings are expected to grow with 41.97% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.97%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

COSM does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

COSMOS HEALTH INC

NASDAQ:COSM (2/21/2025, 8:10:38 PM)

After market: 0.615 0 (-0.24%)

0.6165

-0.01 (-1.89%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-14 2024-11-14/amc
Earnings (Next)08-04 2025-08-04
Inst Owners3.33%
Inst Owner Change-32.49%
Ins Owners8.99%
Ins Owner Change7.69%
Market Cap14.34M
Analysts82.86
Price Target3.06 (396.35%)
Short Float %2.83%
Short Ratio1.18
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-153.06%
Min EPS beat(2)-301.07%
Max EPS beat(2)-5.04%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-14.09%
Min Revenue beat(2)-15.09%
Max Revenue beat(2)-13.09%
Revenue beat(4)1
Avg Revenue beat(4)-4.24%
Min Revenue beat(4)-15.09%
Max Revenue beat(4)12.94%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-25%
EPS NQ rev (1m)18.18%
EPS NQ rev (3m)-12.5%
EPS NY rev (1m)0%
EPS NY rev (3m)-62.5%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-17.38%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.82%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 60.44
P/S 0.26
P/FCF N/A
P/OCF N/A
P/B 0.41
P/tB 0.53
EV/EBITDA N/A
EPS(TTM)-2.23
EYN/A
EPS(NY)0.01
Fwd EY1.65%
FCF(TTM)-0.29
FCFYN/A
OCF(TTM)-0.13
OCFYN/A
SpS2.41
BVpS1.5
TBVpS1.17
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -52.41%
ROE -96.67%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 8.1%
FCFM N/A
ROA(3y)-54.86%
ROA(5y)-35.31%
ROE(3y)-196.24%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-17.56%
GM growth 5Y4.63%
F-Score5
Asset Turnover0.87
Health
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 363.84%
Cap/Sales 6.97%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.44
Quick Ratio 1.24
Altman-Z -1.93
F-Score5
WACC7.49%
ROIC/WACCN/A
Cap/Depr(3y)618.49%
Cap/Depr(5y)438.25%
Cap/Sales(3y)5.46%
Cap/Sales(5y)3.66%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)71.84%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-70.16%
EPS Next Y-21.87%
EPS Next 2Y41.97%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)13.03%
Revenue growth 3Y-1.24%
Revenue growth 5Y7.56%
Sales Q2Q%-3.22%
Revenue Next Year6.66%
Revenue Next 2Y15.46%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-28.29%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year73.3%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-5.16%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y51.94%
OCF growth 3YN/A
OCF growth 5YN/A